There is increasing evidence for interactions among adenosine receptor subtypes in the brain and heart. The purpose of this study was to determine whether the adenosine A(2a) receptor modulates the infarct size-reducing effect of preischemic administration of adenosine receptor agonists in intact rat myocardium. Adult male rats were submitted to in vivo regional myocardial ischemia (25 min) and 2 h reperfusion. Vehicle-treated rats were compared with rats pretreated with the A(1) agonist 2-chloro-N(6)-cyclopentyladenosine (CCPA, 10 mug/kg), the nonselective agonist 5'-N-ethylcarboxamidoadenosine (NECA, 10 mug/kg), or the A(2a) agonist 2-[4-(2-carboxyethyl)phenethylamino]-5'-N-methylcarboxamidoadenosine (CGS-21680, 20 mug/kg). Additional CCPA- and NECA-treated rats were pretreated with the A(1) antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX, 100 mug/kg), the A(2a)/A(2b) antagonist 4-(-2-[7-amino-2-{2-furyl}{1,2,4}triazolo{2,3-a} {1,3,5}triazin-5-yl-amino]ethyl)phenol (ZM-241385, 1.5 mg/kg) or the A(3) antagonist 3-propyl-6-ethyl-5[(ethylthio)carbonyl]-2-phenyl-4-propyl-3-pyridine carboxylate (MRS-1523, 2 mg/kg). CCPA and NECA reduced myocardial infarct size by 50% and 35%, respectively, versus vehicle, but CGS-21680 had no effect. DPCPX blunted the bradycardia associated with CCPA and NECA, whereas ZM-241385 attenuated their hypotensive effects. Both DPCPX and ZM-241385 blocked the protective effects of CCPA and NECA. The A(3) antagonist did not alter the hemodynamic effects of CCPA or NECA, nor did it alter adenosine agonist cardioprotection. None of the antagonists alone altered myocardial infarct size. These findings suggest that although preischemic administration of an A(2a) receptor agonist does not induce cardioprotection, antagonism of the A(2a) and/or the A(2b) receptor blocks the cardioprotection associated with adenosine agonist pretreatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1152/ajpheart.00675.2006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The different effects of four adenosine receptors in liver fibrosis.
Front Pharmacol
September 2024
Department of Obstetrics and Gynecology, Hainan Branch of PLA General Hospital, Sanya, China.
Article Synopsis
- The study investigates the roles of different adenosine receptors (A1R, A2AR, A2BR, A3R) in liver fibrosis, noting that A1R and A2AR may worsen the condition while A2BR and A3R could help alleviate it.
- Using mouse models of liver fibrosis, various adenosine receptor agonists were tested, showing that A1R and A2AR activation increases liver damage and cellular proliferation, whereas A2BR and A3R activation helps reduce fibrosis symptoms.
- The findings indicate that targeting specific adenosine receptors could be a potential therapeutic strategy for managing liver fibrosis, with NECA, an adenosine analog, showing promising results in reducing fibrosis and
Adenosine A receptor and vascular response: role of soluble epoxide hydrolase, adenosine A receptor and angiotensin-II.
Mol Cell Biochem
May 2021
Pharmaceutical Sciences, School of Pharmacy, Center for Basic and Translational Stroke Research, West Virginia University Morgantown, Morgantown, WV, USA.
Previously, we have reported that the coronary reactive hyperemic response was reduced in adenosine A receptor-null (AAR) mice, and it was reversed by the soluble epoxide hydrolase (sEH) inhibitor. However, it is unknown in aortic vascular response, therefore, we hypothesized that AAR-gene deletion in mice (AAR) affects adenosine-induced vascular response by increase in sEH and adenosine A receptor (AAR) activities. AAR mice showed an increase in sEH, A AR and CYP450-4A protein expression but decrease in CYP450-2C compared to C57Bl/6 mice.
View Article and Find Full Text PDFProbe dependence of allosteric enhancers on the binding affinity of adenosine A -receptor agonists at rat and human A -receptors measured using NanoBRET.
Br J Pharmacol
April 2019
Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
Background And Purpose: Adenosine is a local mediator that regulates a number of physiological and pathological processes via activation of adenosine A -receptors. The activity of adenosine can be regulated at the level of its target receptor via drugs that bind to an allosteric site on the A -receptor. Here, we have investigated the species and probe dependence of two allosteric modulators on the binding characteristics of fluorescent and nonfluorescent A -receptor agonists.
View Article and Find Full Text PDFEnhanced A adenosine receptor-induced vascular contractions in mesenteric artery and aorta of in L-NAME mouse model of hypertension.
Eur J Pharmacol
January 2019
Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, USA; Center for Translational Science Institute, West Virginia University, Morgantown, WV, USA. Electronic address:
L-NAME-induced hypertension is commonly used to study endothelial dysfunction and related vascular effects. It has been reported that genetic deletion of A adenosine receptor (AR) reduces blood pressure (BP) increases in mice and thus, suggesting the involvement of AAR. Thus, we sought to determine whether AAR-induced vascular responses were altered in this mouse model of hypertension.
View Article and Find Full Text PDFBlood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A and A.
Mol Neurobiol
June 2018
Section of Medical Biochemistry, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.
The blood-brain barrier (BBB) is mainly made up of tightly connected microvascular endothelial cells (BMECs), surrounded by pericytes (BMPCs) which regulate BBB tightness by providing soluble factors that control endothelial proliferation. Haemophilus influenzae type a (Hia) is able to reach the BBB, crossing it, thus causing meningitis. In this study, by using an in vitro model of BBB, performed with human BMECs and human BMPCs in co-culture, we demonstrated that, after Hia infection, the number of hBMPCs decreased whereas the number of hBMECs increased in comparison with non-infected cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!